Sugi Predict

Sugi Predict / Compounds / SCHEMBL2853523

SCHEMBL2853523

SCHEMBL2853523

CCCCCCCC1CCC(=O)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 5/20 0.50
▸ EPHX1 P07099 1/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ TLR4 O00206 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ PKM P14618 1/20 0.38
▸ CHRM2 P08172 1/20 0.38
▸ CHRM4 P08173 1/20 0.38
▸ CHRM5 P08912 1/20 0.38
▸ CHRM1 P11229 1/20 0.38
▸ DRD2 P14416 1/20 0.38
▸ CHRM3 P20309 1/20 0.38
▸ DRD4 P21917 1/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ CCR2 P41597 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ CYP2D6 P10635 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8640867 1.00 CYP1A2 (0.50) CYP1A2EPHX1MEN1KMT2ATLR4
SCHEMBL16730084 1.00 CYP1A2 (0.50) CYP1A2EPHX1MEN1KMT2ATLR4
SCHEMBL9356259 1.00 CYP1A2 (0.50) CYP1A2EPHX1MEN1KMT2ATLR4
SCHEMBL9139886 1.00 CYP1A2 (0.50) CYP1A2EPHX1MEN1KMT2ATLR4
SCHEMBL11082717 1.00 CYP1A2 (0.50) CYP1A2EPHX1MEN1KMT2ATLR4
SCHEMBL11036095 1.00 CYP1A2 (0.50) CYP1A2EPHX1MEN1KMT2ATLR4
SCHEMBL6736225 1.00 CYP1A2 (0.50) CYP1A2EPHX1MEN1KMT2ATLR4
SCHEMBL9013411 0.98 CYP1A2 (0.49) CYP1A2EPHX1MEN1KMT2ATLR4
SCHEMBL9013646 0.98 CYP1A2 (0.49) CYP1A2EPHX1MEN1KMT2ATLR4
SCHEMBL9013415 0.98 CYP1A2 (0.49) CYP1A2EPHX1MEN1KMT2ATLR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4620945-A1 CATIONIC LIPIDS AND METHOD FOR PREPARING SAME Samyang Holdings Corporation (KR) 2025-09-24 — — EP disclosed
CN-120129674-A Cationic lipids and methods of making the same 三养控股公司 2025-06-10 — — CN disclosed
WO-2024106715-A1 CATIONIC LIPIDS AND METHOD FOR PREPARING SAME 주식회사 삼양홀딩스 2024-05-23 — — WO disclosed
EP-2206695-B1 TETRA- OR PENTA-CYCLIC LIQUID CRYSTALLINE COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT JNC CORP (JP) 2013-09-18 — — EP disclosed
EP-2206695-B1 TETRA- OR PENTA-CYCLIC LIQUID CRYSTALLINE COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT JNC CORP (JP) 2013-09-18 — — EP disclosed
US-8187494-B2 Four- or five-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device JNC CORPORATION (JP) 2012-05-29 — — US disclosed
US-8187494-B2 Four- or five-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device JNC CORPORATION (JP) 2012-05-29 — — US disclosed
US-20100309402-A1 FOUR- OR FIVE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE CHISSO CORPORATION (JP) 2010-12-09 — — US disclosed
US-20100309402-A1 FOUR- OR FIVE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE CHISSO CORPORATION (JP) 2010-12-09 — — US disclosed
EP-2206695-A1 TETRA- OR PENTA-CYCLIC LIQUID CRYSTALLINE COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY ELEMENT Chisso Corporation (JP) 2010-07-14 — — EP disclosed
WO-1987003870-A1 LIQUID CRYSTAL ISOTHIOCYANATE DERIVATIVES MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1987-07-02 — — WO disclosed
EP-0198714-A1 Liquid cristalline compositions containing cyclohexylcyclohexene derivatives, and their use DAINIPPON INK AND CHEMICALS, INC. (JP) 1986-10-22 — — EP disclosed
US-4617141-A LIQUID CRYSTALS CHISSO CORPORATION (JP) 1986-10-14 — — US disclosed
EP-0096850-B1 TRANS-4-ALKYLOXYMETHYL-1-(4'-SUBSTITUTED BIPHENYLYL-4)CYCLOHEXANES AND LIQUID CRYSTAL COMPOSITIONS CONTAINING THE SAME Chisso Corporation (JP) 1985-09-25 — — EP disclosed
US-4522741-A Trans-4-alkyloxymethyl-1-(4'-substituted biphenylyl-4)cyclohexanes CHISSO CORPORATION (JP) 1985-06-11 — — US disclosed
EP-0096850-A1 Trans-4-alkyloxymethyl-1-(4'-substituted biphenylyl-4)cyclohexanes and liquid crystal compositions containing the same Chisso Corporation (JP) 1983-12-28 — — EP disclosed
US-4345073-A 7,7'-Diamino derivatives of 2,2'-spirodibenzopyranes BASF AKTIENGESELLSCHAFT (DE) 1982-08-17 — — US disclosed
US-4316027-A DYE INTERMEDIATES USED IN THE MANUFACTURE OF PRESSURE SENSITIVE RECORDING MATERIAL BASF AKTIENGESELLSCHAFT (DE) 1982-02-16 — — US disclosed
US-4130502-A Liquid crystalline cyclohexane derivatives MERCK PATENT GESELLSCHAFT MIT (DE) 1978-12-19 — — US disclosed
US-4110348-A PRESSURE SENSITIVE RECORDING BASF AKTIENGESELLSCHAFT (DE) 1978-08-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100309402-A1 FOUR- OR FIVE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE KIF23, HCN3, FZD7 CYP1A2 2155/4885EPHX1 3086/4885MEN1 3734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.